<DOC>
	<DOCNO>NCT02757170</DOCNO>
	<brief_summary>Patients acute &amp; chronic liver failure long assume coagulopathy &amp; give blood product prophylactically well various intervention . But patient rarely spontaneous bleed except variceal bleed . Conventional coagulation parameter insufficient assess coagulation status patient reflect certain element coagulation cascade thromboelastography ( TEG ) give comprehensive report hemostatic profile include platelet function . Studies use TEG suggest defect prohemostatic driver counterbalance change antihemostatic driver create rebalance patient . Acute chronic failure entity acute decompensation underlie chronic liver failure . Since paucity data regard coagulation abnormality patient , study need assess predictability power TEG patient respect coagulation abnormality patient ALF CLD ( cirrhosis ) healthy control .</brief_summary>
	<brief_title>Assessment Coagulation Abnormalities Acute Chronic Liver Failure Patients Using Thromboelastography</brief_title>
	<detailed_description>Since early time coagulopathy consider integral part liver failure . Whether acute liver failure ( ALF ) acute chronic liver failure ( ACLF ) , patient usually derange coagulation parameter ( platelet count , prothrombin time ( PT ) , activate partial thromboplastin time ( aPTT ) international normalize ratio ( INR ) . Based deranged parameter , initially assume patient liver failure increase risk bleeding &amp; usually give blood product prophylactically surgical intervention . But patient liver failure ( acute chronic ) seldom develop spontaneous bleeding , apart variceal bleed chronic liver failure generally occur portal hypertension . Moreover invasive procedure also significant bleeding . Concept rebalanced hemostasis propose explain discrepancy result coagulation parameter &amp; clinical scenario patient . Normal hemostasis consist 3 step : platelet endothelial interaction , coagulation &amp; fibrinolysis . First step consider defective liver failure thrombocytopenia &amp; qualitative platelet dysfunction . However decreased plasma concentration ADAMTS 13 , plasma level vwF increase thus increase stickiness platelet &amp; rebalancing primary hemostasis . Because deranged INR , think coagulation cascade derange Tripodi et al show cirrhotics also generate amount thrombin healthy subject . All procoagulants ( factor II , V , VII , IX , X , XI ) &amp; anticoagulant factor ( protein C , protein S &amp; antithrombin ) except factor VIII synthesize liver . Decreased procoagulant activity find counterbalance decreased anticoagulant protein , thus rebalancing whole coagulation process . Finally , increase fibrinolytic activity clot instability increase tissue plasminogen activator ( tPA ) low level alpha 2 antiplasmin , factor XIII reduce thrombin activate fibrinolysis inhibitor ( TAFI ) . However , balance increase level acute phase reactant plasminogen activator inhibitor ( PAI-1 ) . Conventional parameter like INR although predict mortality case n't predict risk bleeding patient monitor part coagulation cascade . These parameter assess clot formation plasma environment Thromboelastography ( TEG ) whole blood i.e . plasma &amp; cellular component include platelet assess &amp; collective report hemostatic profile patient available . Graph obtain use TEG give 5 value include r time , k time , Î± angle , maximum amplitude &amp; lysis 30 min assess different aspect . It widely use prior cardiac surgery liver transplant surgery ass coagulation defect . In patient stable cirrhosis , TEG parameter report lie within normal limit . TEG measurement do serially show good routine coagulation test measure hypocoagulability cirrhotics early rebleeding . In decompensated cirrhotic patient , bacterial infection common impair hemostasis . The TEG parameter impair day infection recover normal value 5 day case show response treatment . The result TEG ALF contrast two study include predominantly paracetamol induced ALF . Stravitz et al study 51 ALF patient report normal TEG 63 % , 1 abnormality 16 % , 2 abnormality 10 % , 3 abnormality 8 % patient 4 abnormality 4 % whereas 8 % patient TEG parameter hypercoagulable range though mean parameter within normal limit patient . In another study 20 ALF patient , TEG find consistent hypocoagulable state 20 % , normal 45 % , hypercoagulable 35 % patient . Acute chronic liver failure recently define entity prolong INR component definition . The exact nature coagulopathy disease yet study . In prospective study , propose study role TEG assess coagulation state patient ACLF compare TEG parameter respect patient ALF , CLD healthy control .</detailed_description>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>End Stage Liver Disease</mesh_term>
	<mesh_term>Acute-On-Chronic Liver Failure</mesh_term>
	<criteria>1 . All consecutive ALF , ACLF &amp; cirrhotic patient healthy control 2 . Written informed consent ( patient nearest relative ) 1 . Patients antiplatelet anticoagulant therapy 2 . Pregnancy immediate postpartum period 3 . History underlie hypercoagulable/ hypocoagulable state eg . PNH , Polycythemia , Hemophilia 4 . Patients renal failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>